I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A cost-effectiveness analysis of PHiD-CV compared to PCV13 ..:
Youness Lagoubi
;
Mohamed Tahar Sfar
;
Jorge A. Gomez
http://dx.doi.org/10.1080/21645515.2022.2079305. , 2022
Link:
https://doi.org/10.1080/21645515.2022.2079305
RT Journal T1
A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:cddce0097de54bbb90675bec9de910c3&Exemplar=1&LAN=DE A1 Youness Lagoubi A1 Mohamed Tahar Sfar A1 Jorge A. Gomez PB Taylor & Francis Group YR 2022 K1 streptococcus pneumoniae K1 pneumococcal conjugate vaccine K1 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine K1 13-valent pneumococcal conjugate vaccine K1 pcv10 K1 pcv13 K1 cost-effectiveness K1 tunisia K1 invasive pneumococcal disease K1 acute otitis media K1 phid-cv K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2022.2079305 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2022.2079305 DO https://doi.org/10.1080/21645515.2022.2079305 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)